We found that only MDM4 (HR = 6.424, p = 0.021) and LAMP2 (HR = 0.119, p = 0.045) were significantly associated with OS in prostate cancer, and no significant association was found in the analysis of DSS. Here, MDM4 is linked to prostate carcinoma.